Endocrinology. Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

By Howles C.M.  

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 1939-1943

Oxford University Press

Access to resources Recommend Favorite

Vascular endothelial growth factor and its soluble receptor in ovarian pathology

By Artini PG   Cristello F   Monti M   Cela V   Battaglia C   D'Ambrogio G   Genazzani AR  

Gynecological Endocrinology, Vol. 21, Iss. 1, 2005-07 ,pp. : 50-56

Informa Healthcare

Access to resources Recommend Favorite

Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome

By Pau Elena   Alonso-Muriel Isabel   Gómez Raul   Novella Edurne   Ruiz Amparo   García-Velasco Juan A.   Simón Carlos   Pellicer Antonio  

Human Reproduction, Vol. 21, Iss. 6, 2006-06 ,pp. : 1453-1460

Oxford University Press

Access to resources Recommend Favorite

Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast

By Munaut Carine   Lorquet Sophie   Pequeux Christel   Blacher Sylvia   Berndt Sarah   Frankenne Francis   Foidart Jean-Michel  

Human Reproduction, Vol. 23, Iss. 6, 2008-06 ,pp. : 1407-1415

Oxford University Press

Access to resources Recommend Favorite

Circulating levels of free and total vascular endothelial growth factor (VEGF)‐A, soluble VEGF receptors‐1 and ‐2, and angiogenin during ovarian stimulation in non‐human primates and women

By  

Human Reproduction, Vol. 19, Iss. 4, 2004-04 ,pp. : 822-830

Oxford University Press

Access to resources Recommend Favorite